Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.93 USD | -4.67% |
|
-4.55% | -43.44% |
| 05-07 | Boston Scientific to Update Pacemakers in Recall, FDA Says | DJ |
| 05-07 | US FDA issues recall of Boston Scientific heart devices | RE |
| Capitalization | 80.16B 68.1B 62.33B 58.83B 110B 7,570B 111B 739B 288B 3,636B 301B 294B 12,554B | P/E ratio 2026 * |
19.9x | P/E ratio 2027 * | 18.8x |
|---|---|---|---|---|---|
| Enterprise value | 86.45B 73.45B 67.22B 63.45B 118B 8,165B 119B 797B 311B 3,922B 324B 318B 13,540B | EV / Sales 2026 * |
3.99x | EV / Sales 2027 * | 3.52x |
| Free-Float |
84.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | -4.67% | ||
| 1 week | -4.55% | ||
| Current month | -6.39% | ||
| 1 month | -13.79% | ||
| 3 months | -29.29% | ||
| 6 months | -46.08% | ||
| Current year | -43.44% |
| 1 week | 53.63 |  | 58.18 |
| 1 month | 53.63 | | 66.88 |
| Current year | 53.63 | | 100.9 |
| 1 year | 53.63 | | 109.5 |
| 3 years | 48.35 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 2011-10-31 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 2025-06-29 |
John Sorenson
COO | Chief Operating Officer | 58 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 74 | 2014-02-28 |
Ellen Zane
BRD | Director/Board Member | 74 | 2016-04-14 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.34% | 1.75% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.67% | -4.55% | -47.79% | +1.52% | 80.16B | |
| -1.99% | -0.90% | +13.20% | -14.30% | 173B | |
| -0.76% | -1.69% | -16.37% | +48.49% | 159B | |
| -2.56% | -2.28% | -12.14% | -28.46% | 121B | |
| -3.38% | -4.79% | +7.14% | -10.18% | 46.04B | |
| -0.85% | -3.56% | -27.72% | -41.48% | 44.18B | |
| +1.32% | +15.63% | +1.21% | +19.77% | 34.86B | |
| -2.55% | +0.96% | +6.37% | -12.71% | 32.67B | |
| +0.06% | +1.31% | -24.46% | -43.35% | 30.34B | |
| -0.06% | +0.85% | -14.95% | -11.15% | 29.99B | |
| Average | -1.28% | -0.27% | -11.55% | -9.18% | 75.16B | |
| Weighted average by Cap. | -1.41% | -1.16% | -9.93% | -2.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.68B 18.42B 16.86B 15.91B 29.68B 2,048B 29.94B 200B 77.95B 983B 81.34B 79.63B 3,395B | 23.62B 20.07B 18.36B 17.33B 32.33B 2,231B 32.62B 218B 84.92B 1,071B 88.61B 86.75B 3,699B |
| Net income | 3.96B 3.36B 3.08B 2.9B 5.42B 374B 5.47B 36.51B 14.23B 180B 14.85B 14.54B 620B | 4.18B 3.55B 3.25B 3.07B 5.72B 395B 5.77B 38.53B 15.02B 190B 15.67B 15.34B 654B |
| Net Debt | 6.29B 5.35B 4.89B 4.62B 8.62B 594B 8.69B 58.05B 22.63B 286B 23.61B 23.12B 986B | 2.9B 2.46B 2.25B 2.13B 3.97B 274B 4B 26.74B 10.42B 132B 10.88B 10.65B 454B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-08 | 53.93 $ | -4.67% | 20,841,325 |
| 26-05-07 | 56.57 $ | +1.02% | 25,541,289 |
| 26-05-06 | 56.00 $ | +0.04% | 18,680,175 |
| 26-05-05 | 55.98 $ | -1.53% | 12,544,097 |
| 26-05-04 | 56.85 $ | +0.62% | 13,975,262 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition